drugset / Trial / NCT00636207
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)
RandomizedParallel-groupDouble-blindTreatment
Summary
A study to evaluate the safety, tolerability and pharmacokinetics of inhaled Montelukast (MK-0476) in participants with mild or moderate asthma.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-09
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 0.1 mg | Inhaled |
| Subject | Montelukast | Other / unclassified | 0.3 mg | Inhaled |
| Subject | Montelukast | Other / unclassified | 1 mg | Inhaled |
| Subject | Montelukast | Other / unclassified | 3 mg | Inhaled |
| Subject | Montelukast | Other / unclassified | 10 mg | Inhaled |